Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the
UnitedHealth First-Quarter Earnings, Revenue Up as Company Added Members
Business Earnings Company sees moderate health spending, but higher costs for drugs such as Ozempic Source link
First Week of April 21st Options Trading For BioCryst Pharmaceuticals (BCRX)
Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost
HC Wainwright & Co. Reiterates Acurx Pharmaceuticals (ACXP) Buy Recommendation
Fintel reports that on April 11, 2023, HC Wainwright & Co. reiterated coverage of Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy recommendation. Analyst Price Forecast Suggests
Albertsons Earnings Shrink Amid Difficult Consumer Environment
Business Earnings Supermarket chain braces for significant labor investments, inflation cost increases Source link
Former Outcome Health Executives Found Guilty of Fraud
Business Health Care Health Verdict caps fall of startup’s executive team led by Rishi Shah, who could face years in prison Source link
Ozempic, Wegovy and Mounjaro Spark a Weight-Loss and Diet Industry Identity Crisis
Weight-loss businesses, which long pushed calorie-counting and willpower, are grappling with the surging popularity of new drugs. Source link
Johnson & Johnson’s Talc Plan Spotlights Chapter 11 Voting Power
Johnson & Johnson’s latest plan to resolve mass cancer lawsuits through bankruptcy could force some cosmetic-talc users and their lawyers into a settlement they don’t
Exxon Mobil, Johnson & Johnson, Alphabet: Stocks That Defined the Week
Markets Stocks Here are seven major companies whose stocks moved on the week’s news Source link
FDA Forces the Only Drug for Preterm Births to Leave Market
Health Makena injections for pregnant women with previous early births are ineffective, agency says Source link